Alto Neuroscience, Inc. (ANRO) stock
ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
$25.91+1.00 (+4.01%)
Close on Nov 18, 2026Market cap $1.02BP/E –Yield –
Alto Neuroscience revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Alto Neuroscience
Alto Neuroscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?